MediWound logo
MediWound
MDWD | NASDAQ
Chart Builder DCF Calculator
$13.55
+$0.65 (+5.04%)
At close: Nov 16, 2026, 4:00 PM ET
$13.55
$0.00 (0.00%)
After-hours: Nov 16, 2026, 4:10 PM ET

MediWound Company Profile

Company profile explained

Company Profile

MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel, bio-therapeutic, and non-surgical solutions for tissue repair and regeneration in the United States, Germany, Italy, Spain, and internationally. The company markets NexoBrid, a biopharmaceutical product for the removal of eschar in patients with deep partial- and full-thickness thermal burns to burn centers and hospitals burn units. It also develops EscharEx, a bromelain-based, bioactive enzymatic therapy for the treatment of chronic wounds and other hard-to-heal wounds; and MW005, a topically applied biological product candidate to treat non-melanoma skin cancers. MediWound Ltd. was incorporated in 2000 and is headquartered in Yavne, Israel.

Key Executives

Name Position
Ofer Gonen Chief Executive Officer
Hani Luxenburg Chief Financial Officer
Shmulik Hess Chief Operating Officer & Chief Commercial Officer
Barry J. Wolfenson Executive Vice President of Strategy & Corporate Development
Ety Klinger Chief Medical Officer
Liron Gal Vice President of Manufacturing Science & Technology
Robert J. Snyder FFPM Senior Vice President of Global Medical Affairs
Yaron Meyer Adv. Executive Vice President, General Counsel & Corporate Secretary

Latest SEC Filings

Date Type Title
Sep 02, 2026 4 Filing
Aug 28, 2026 4 Filing
Aug 28, 2026 SC 13G/A [Amend] Statement of acquisition of beneficial own...
Aug 14, 2026 SC 13G/A [Amend] Statement of acquisition of beneficial own...
Aug 13, 2026 6-K Filing
Jun 04, 2026 4 Filing
Jun 02, 2026 4 Filing
Jun 01, 2026 4 Filing
May 27, 2026 6-K Filing
May 15, 2026 SC 13G Statement of acquisition of beneficial ownership b...
View All SEC Filings ➞
MediWound
MediWound logo
Country Israel
IPO Date Mar 20, 2014
Industry Biotechnology
Sector Healthcare
Employees 121
CEO Ofer Gonen

Contact Details

42 Hayarkon Street Yavne, HM 8122745 Israel

Stock Details

Ticker Symbol MDWD
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001593984
CUSIP Number M68830112
ISIN Number IL0011316309
SIC Code 2833

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.